SEARCH RESULTS

HelioScreen, In Vitro evaluation specialist in sun screen products entering India

Thomas ILHE - 13-avr.-2015 11:36:44
HelioScreen , a French company involved in evaluation of sun protection products has entered Indian market partnering with C.L.A.I.M.S   Pvt Ltd , a Mumbai based CRO specializing in clinical research in the area of skin, hair and body care. 15 year old Helioscreen is a laboratory providing services for testing any products (cosmetics, textile, clothes etc.) in regard of their properties for UV /sun protection by means of In Vitro testing. With their profound involvement in R&D, and conceptualized a very particular kind of ‘robot’ which is considered as a performer in UV protection as it ensures consistency during In Vitro testing. LSW met Dr. Dominique Lutz, CEO and found out more about sunscreen technology and his company HelioScreen.  Excerpts from the interview conducted during his visit to Mumbai. Dr. Dominique Lutz CEO, Helioscreen LSW : In general, some of the sunscreen agents which are in use are uncertain on safety and efficacy. What are your views on this? Dr. Dominique Lutz : As long I know and considering the most important companies, we cannot state some ingredients are uncertain on safety. I know some debates on some of them but it is not a tremendous problem. Clearly the industries have to comply with the quality of these ingredients. The same filter (i.e. bmdbm now out of its patent) can be produced on bad conditions and include by product. But this is another story. Now considering the purpose of product including sun filters, I would totally agree we can state some products are uncertain on safety if we mean the safety is to protect the consumer from harmful UV exposure, some time it may be better not to be protected than protected by a “bad” product. And a so called bad product may be a product which claims a high SPF protection only in the UVB range. This has been the starting point to define a new way of protection including UVB and UVA and balanced effect on the all spectrum. It is far from being followed and even check with testing in some companies. LSW: Claims of water-proof, instant protection etc are misguiding users particularly when it comes to cosmetics. Your comment. Dr. Lutz : I totally agree even if cosmetics are efficient this is a pity that the marketing claims, lead the customer to be misguided for its use or the benefits he can expect from the product sometimes it may also be dangerous and claims must be controlled with attention by the authorities. As an example claim of full UV screen may induce customer not to pay attention with an over exposure. Sometimes it could be helpful and efficient to explain to the consumers as an example a product needs to be spread long before exposing and more efficient if renewed frequently in order to make it to perform “normally”. There is a chemical process and it is not enough just to spread the product at the last moment. May be the marketing should be first informed to give the good advice. LSW : Many sun screening products are available in India, but the composition details are not clear because most of them are cosmetic products. How do you propose to go about this in your foray in the Indian market? Dr. Lutz : : I think the rules in EU or other countries to exhibit CTFA formula is something logical. It is not so complicated to put in place but I think India health authorities have a lot to do to go towards international standard for claiming, demonstrating, testing etc… LSW : Unlike the US FDA and EU guidelines, in India there are no set guidelines for standardization. Some of the agents are manufactures by pharmaceuticals companies as combination products like cosmetics. Will you be focusing only on cosmetic area pertaining to skin, hair and body care? Dr. Lutz : Most of the time yes because they are these rules and guideline which are compulsory and so plenty of requirement to market a product. Nevertheless ourknow about is to measure the UV transmission (or no UV transmission) and we have had plenty of different works done on specific material. Just let me take as example textile, Sun glasses or even plaster. Let me also precise the countries in which we have the most important market are not automatically the ones in which they are the rules. In that case there is a hard competition and sometimes customers just care about the report and not the quality of the information. In Vitro AND in vivo tests can be really variable, any one would agree with this statement. At the same time, industrials or laboratories when developing need some tools to be efficient. It is not with your expertise, long experience you can guarantee a results even choosing the best ingredients. Only some specific tests most of the time different from the ones for claiming are the tolls to ensure and potentialize the results. LSW : Generally, sun screens are available in the cream. Lotion, sprays which are OTC (over the counter) products. Are you planning to look into pharmacokinetics area? Dr. Lutz : We already work with pharmaceutical companies in France. When a product needs a certification to be classified as a medicine, plenty of tests which have nothing to see with the claiming tests are required by the authorities. Also we did some method on photo stability for the Canadian health authorities etc…Clearly it also depends on the rules of each country. LSW : Now that HelioScreen is entering the Indian market, with a focus on personal care products which is a competitive market. Do you plan to look at offering your solutions to other areas also? Dr. Lutz : Considering the testing for UV protection efficiency there is so much to do and in fact no yet competitors, we prefer to be concentrated that allow us to be really a specialist as required for such a task. LSW : you share some information on HelioScreen’s partnership with C.L.A.M.S Dr. Lutz : We have had plenty of proposals from India but CLAIMS is doing the same job means TESTING and they have the serious and organization to propose complementary tests they cannot perform themselves. They have the background to explain the technique and it is not only a business opportunity but a real partnership. LSW : Finally, a brief history of your company and the future plans in India in particular. Dr. Lutz : Helioscreen has been created 15 Y ago with the only aim to propose in vitro testing services for sun screen evaluation. But at that time in EU, there were no methods, no market, and no trust in these services. Just my conviction it will be the future with my experience within COLIPA and a solid relationship with French Industries. Also the opportunity when I quit the industry to became an independent expert nearby French Health authorities and the possibility to work and contribute a lot both on a technical point of view and also political in EU Commission. Afterwards we have been logically involved in the ISO worldwide process as expert. My company has become more important and now has competitors but we have proposed the most important innovations in the development of these methods and will stay forever the forerunner. Today our contribution in RD in very huge compared to the size of my company. Also the development all over the word as these methods must be applied all over the word to be efficient. We can take for sure the future SPF standard on which we are working for decades in the international committee will have been proposed from our laboratory. LSW : Any other information that you would like to share with. Dr. Lutz : Unless in a country where there is still few constraint to put a product on the market the new requirement for sun protection claiming are more and more understood by consumers. Also keeping with the technical requirements about protection ( UVB/UVA) is not so easy, so it is better to be ready for the very next future of the legislation and requirement from consumers than wait for compulsory rules from authorities. That will make the difference. Source: Life Science World, Interview of Dr. Dominique Lutz, HelioScreens CEO, with Sanker Iyer http://lifescienceworld.in/highlight/vitro-evaluatio-%20specialist-in-sun-screen-products-entering-india.html

Pierre Fabre Dermocosmetic and Abbott Healthcare strengthen their partnership for the best French skincare range in India

Ridhima Verma - 05-mars-2015 08:06:37
    Pierre Fabre Dermocosmetic and Abbott Healthcare strengthen their partnership for the best French skincare range in India   ~ Avène Ducray & A-Derma products to re-define care for Indian skin ~ Mumbai, February 27, 2015: Pierre Fabre Dermo-cosmetic, 2nd largest dermo ‐ cosmetics laboratory in the World and Abbott Healthcare Pvt. Ltd., one of India’s largest pharmaceutical & healthcare companies have today announced the renewal of their partnership for commercialisation in India of 3 unique dermo-cosmetic ranges, namely AVÈNE, DUCRAY and A-DERMA .   AVÈNE products are formulated with the unique Avène Thermal Spring Water that runs in the South of France. They specialize in highly sensitive skincare, and are globally recommended for Sensitive, Atopic, Intolerant and Allergy prone skin. DUCRAY is the most medical brand existing on the dermo-cosmetic market and A-DERMA is exclusively formulated with Rhealba® oat cultivated organically in the South of France and offering unique soothing properties. This vast range of products covers Cleansing , Moisturizing , Anti-Ageing , Anti-Acne , Sun Protection , Hyper-pigmentation but also healing for atopic and sensitive skins. Pierre Fabre Dermo-cosmetic ranges promise to fulfil the needs of every skin type in India by offering variants for dry, normal and a combination skin.     “Abbott’s partnership with Pierre Fabre shows our commitment to bring to India globally renowned derma-cosmetic formulations.   Its AVÈNE, DUCRAY and A-DERMA globally popular brands addresses multitudes of skin concerns of people with sensitive skin or irritated skin; and preserving health and beauty of normal skin and hair,” said M. Sudarshan Jain, Managing Director of Abbott Healthcare.”     “Pierre Fabre’s background as a pharmaceutical company specializing in Dermatology in addition with its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbott. In order to fulfil the highest expectations of sensitive or fragile skins, clinical and consumer tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin.”   Added M. Eric Ducournau, Chairman Pierre Fabre Dermo-Cosmetics.   Commenting on their plans in the Indian market , M. Pierre BEHNAM, Country Head Indian Operation said, “ The dermo-cosmetic market in India is fairly new but has a lot of potential. The current market size can be pegged at around 100 million Euros (700 Crores Roupies) within 5 years. We have plans to launch 6 new types of products per year and are therefore confident that our premium brands will be instrumental to convert this potential.. ”        T he entire range of Pierre Fabre Dermo-cosmetics products has been meticulously researched and developed to ensure they offer optimal solutions to today’s multiple skin needs particularly in India. Products are available at organized chemist stores across India.   About Pierre Fabre   Pierre Fabre is the 3rd largest French pharmaceutical group and the 2nd largest dermo-cosmetics laboratory in the world. In 2013, its sales reached €2.111 Billion, with Dermo-Cosmetics revenues accounting for 55% and international for 56%. Founded and its headquarters still based in the South-west of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in over 130 countries.   Covering a continuum of healthcare products, from prescription drugs and consumer health care products (OTC, oral care, natural health) to dermo-cosmetics, Pierre Fabre Laboratories employ over 10,000 people worldwide. In 2013, Pierre Fabre allocated more than 17% of its drug revenues to R&D.   With brands such as Avène, Klorane, Ducray, René Furterer, A-Derma, Galénic, Naturactive, Elgydium, Eludril or Drill, Pierre Fabre Laboratories are market leaders when it comes to skin, hair and oral care products distributed in the French pharmacy channel. Avène Thermal Spring Water is marketed worldwide, and is the leading dermo-cosmetics brand sold in Europe, Japan and China. In oncology, Pierre Fabre achieves 90% of its revenues outside of its home country.   Through the Pierre Fabre Participations holding company, the Pierre Fabre Foundation, a government-recognized public-interest foundation, owns 86% of Pierre Fabre Laboratories. Remaining shares are owned by company employees, amounting to 7%, and through treasury stock.   The French certification group AFNOR has audited Pierre Fabre Laboratories for its corporate social responsibility (CSR) performance at advanced level (AFAQ 26 000)   To find out more, please visit www.pierre-fabre.com       About Abbott:   Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 77,000 people.   In India, Abbott has more than 14,000 employees working in manufacturing, research and development, logistics, sales and marketing and is headquartered in Mumbai.   Visit Abbott at   www.abbott.com   and connect with us on Twitter at @AbbottNews .   For media enquiries, please contact:     Pierre Fabre Liaison Office P2 Percept House, 3d Floor Raghuvanshi Mills Compound 11/12 Senapati Bapat Marg, 400 013 Mumbai - India E-MAIL : pierre.behnam@pierre-fabre.com    

HelioScreen will enter the Indian market and announces a partnership

Ridhima Verma - 18-févr.-2015 13:03:33
  HelioScreen, world leader in In Vitro evaluation of sun protection products, will enter the Indian market and announces a partnership with C.L.A.I.M.S Pvt Ltd. Home and Personal Care Ingredients (HPCI) exhibition and conference, 4-5 March 2015, Mumbai HelioScreen, world leader and specialist for more than 15 years of the In Vitro evaluation of sun protection products, has announced their partnership with C.L.A.I.M.S Pvt Ltd. to enter the Indian market. The two companies will be attending the Home and Personal Care Ingredients (HPCI) exhibition and conference in Mumbai from 4th-5th March 2015 . Partnering with C.L.A.I.M.S Pvt Ltd, a Clinical Research Organization which provides specialized Clinical Research and Sensory Evaluation in the area of skin care, hair care and body care, the French company will explore the Indian market for offering their solutions during their visit to India. Taking this opportunity, Dr. Dominique Lutz, HelioScreen CEO, said " As we did shortly in South-Eastern Asia, we decided to be present in India as we consider the country a very strategic market. As increasing disposable incomes continue to change the spending habits of the sizable population and awareness for new formulations grows, India has the potential to become one of the major consumption markets for personal care products. " Helioscreen is a laboratory providing services for testing any products (cosmetics, textile, clothes etc.) in regard of their properties for UV /sun protection by means of In Vitro testing. With their profound involvement in R&D, the expert laboratory formed 15 years ago by Mr. Dominique Lutz has conceptualized a very particular kind of ‘robot’ which is considered as a performer in UV protection as it ensures consistency during In Vitro testing. All over the world there is a great debate about the evaluation of the sun protection for cosmetic products. Most known index is the SPF which is mentioned on all products. For health authorities as well as industries it is far from being enough. In Vivo SPF testing is variable in laboratories, is not enough to express protection as UVA is also required, has faced ethical problems when tested on humans, and has been inconsistent with results due to manual spreading of the product onto the skin which is impossible to control correctly. Nevertheless there is a consensus all over the word to go towards In Vitro method. International ISO TC217 group and its specific ad hoc group of international experts are to put a process of standardization, a method for the In Vitro SPF determination within a short delay. Dr. Lutz, HelioScreen CEO, emphasizing In Vitro said " Very soon In vitro sunscreen testing will substitute In Vivo. An ISO process is in course and the most significant contribution comes from our laboratory with scientifically recognized development of innovative specific equipment. As forerunners for the method we also have to forecast the markets for the next future ." Come visit and meet HelioScreen and C.L.A.I.M.S Pvt. Ltd. at Home and Personal Care Ingredients (HPCI) exhibition and conference, booth number 256, at Bombay Convention and Exhibition Centre in Mumbai. About HelioScreen HelioScreen was founded by Dr. D. Lutz in the year 1997-1998. The company is the world leader and specialist for more than 15 years in In Vitro evaluation of sun protection products. It offers a complete range of tests complying with the various world regulations. Additionally well-known for its publications, communication and development of some branches all over the world, the last one being in Thailand, Asia. About Business France Business France, the French government agency supporting the international development of the French economy was formed through the merger between UBIFRANCE and the Invest in France Agency on January 1, 2015. A key player in fostering competitiveness, growth and employment in France, it advances and promotes business throughout France, and by French companies abroad. From exports to investments through multinational partnerships, Business France supports French and multinational companies throughout the lifetime of their projects.                            
About
Sophie Clavelier, Country Head   Welcome to the French Trade Commission Business France in India!     Our key mission is to promote trade relations between France and India. We assist French- based companies seeking potential partners and new markets in India, while helping Indian businesses to identify potential French suppliers, commercial and technical partners.   In India, our 4 offices are located in business hubs, New Delhi, Mumbai, Bengaluru and Chennai. We have a dedicated multicultural team of 38 experts in the following growing sectors: Agrofood Industry Industry and Cleantech Lifestyle and Healthcare Tech & Services Our Trade Commission also has a Press office in charge of helping French companies to communicate in India as well as a Market Access Department enabling them to better understand and adjust to the Indian regulatory and fiscal framework. In

READ MORE

Facebook
Press area & Media Gallery
List of last comments

Bluestorage is a subsidiary of the Bollo...

Malcolm MESSIER | février 22, 2019

AdBGQi Thank you for this impressive rep...

best pron | janvier 29, 2018

pYktcT Well I definitely liked studying ...

just another | novembre 08, 2017

dv1KAR Say, you got a nice post.Thanks A...

best pron | septembre 20, 2017